These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12928225)

  • 1. Prognostic value of multiple reverse transcription-PCR tyrosinase testing for circulating neoplastic cells in malignant melanoma.
    Szenajch J; Jasiński B; Synowiec A; Kulik J; Chomicka M; Struzyna J; Nowecki Z; Rutkowski P; Ruka W; Kupść W; Siedlecki JA; Wiktor-Jedrzejczak W
    Clin Chem; 2003 Sep; 49(9):1450-7. PubMed ID: 12928225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of tyrosinase and tyrosinase-related protein 1 sequences from peripheral blood of melanoma patients using reverse transcription-polymerase chain reaction.
    Jin HY; Yamashita T; Minamitsuji Y; Omori F; Jimbow K
    J Dermatol Sci; 2003 Dec; 33(3):169-76. PubMed ID: 14643522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma.
    Brownbridge GG; Gold J; Edward M; MacKie RM
    Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
    Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
    Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
    Proebstle TM; Jiang W; Högel J; Keilholz U; Weber L; Voit C
    Br J Cancer; 2000 Jan; 82(1):118-23. PubMed ID: 10638977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
    Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
    J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
    Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
    J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma.
    Schmidt H; Sørensen BS; von der Maase H; Bang C; Agger R; Hokland M; Nexo E
    Melanoma Res; 2002 Dec; 12(6):585-92. PubMed ID: 12459648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of RT-PCR tyrosinase detection in peripheral blood of melanoma patients.
    Carrillo E; Prados J; Marchal JA; Boulaiz H; Martínez A; Rodríguez-Serrano F; Caba O; Serrano S; Aránega A
    Dis Markers; 2006; 22(3):175-81. PubMed ID: 16788251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tyrosinase reverse-transcriptase polymerase chain reaction in metastatic melanoma.
    Quereux G; Denis M; Khammari A; Lustenberger P; Dreno B
    Dermatology; 2001; 203(3):221-5. PubMed ID: 11701975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple RT-PCR tyrosinase testing reveals that melanoma cells circulate in the blood of melanoma patients at the frequency more than 10 times below the detection threshold.
    Szenajch J; Jasinski B; Kozak A; Kulik J; Chomicka M; Struzyna J; Nowecki Z; Rutkowski P; Ruka W; Kupsc W; Siedlecki J; Wiktor-Jedrzejczak W
    Melanoma Res; 2002 Aug; 12(4):399-401. PubMed ID: 12170191
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of prognostic importance of reverse-transcriptase polymerase chain reaction detection of circulating messenger RNA in patients with melanoma.
    Ranieri JM; Wagner JD; Wiebke EA; Azuaje R; Smith ML; Wenck S; Daggy J; Coleman JJ
    Plast Reconstr Surg; 2005 Apr; 115(4):1058-63. PubMed ID: 15793446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma.
    Schittek B; Bodingbauer Y; Ellwanger U; Blaheta HJ; Garbe C
    Br J Dermatol; 1999 Jul; 141(1):30-6. PubMed ID: 10417512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
    Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
    Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma.
    Glumac N; Snoj M; Hocevar M; Novakovic S
    Neoplasma; 2006; 53(1):9-14. PubMed ID: 16416006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR.
    Seiter S; Rappl G; Tilgen W; Ugurel S; Reinhold U
    Recent Results Cancer Res; 2001; 158():105-12. PubMed ID: 11092037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse transcriptase-polymerase chain reaction detection of circulating tumor cells in patients with melanoma: correlation with clinical stage, tumor thickness and histological type.
    Carrillo E; Prados J; Melguizo C; Marchal JA; Vélez C; Serrano S; Boulaiz H; Mérida JA; Aránega A
    Pathol Int; 2002 Apr; 52(4):294-9. PubMed ID: 12031085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detection of circulating melanoma cells correlates with tumour thickness and ulceration but is not predictive of metastasis for patients with primary melanoma.
    Hanekom GS; Stubbings HM; Johnson CA; Kidson SH
    Melanoma Res; 1999 Oct; 9(5):465-73. PubMed ID: 10596913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
    Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.